ISSN 0004-8674; 1440-1614;
4 papers in the library · 9 citations · publishing 2023-2026
Aust N Z J Psychiatry September 28, 2023 4 citations
This letter to the editor comments on a prior article about the need for phenomenology in psychedelic-assisted psychotherapy. It likely offers critique or additional perspective on the role of subjective experience in such treatments, but the abstract provides no specific findings, arguments, or data.
Aust N Z J Psychiatry July 8, 2025 3 citations
Australian clinicians hold mixed views on psychedelic-assisted therapy. A survey of mental health professionals found that while many acknowledge potential therapeutic benefits for conditions such as depression and PTSD, concerns remain about safety, regulatory frameworks, and lack of training. The majority supported further research but were cautious about immediate clinical implementation, with attitudes varying by professional background and prior knowledge of psychedelics.
Aust N Z J Psychiatry November 5, 2023 2 citations
The author responds to a Letter to the Editor, reiterating the argument that phenomenology is essential for understanding subjective experience in psychedelic-assisted psychotherapy. The reply defends the original position that phenomenological methods can provide valuable insights into the nature of these experiences, which may be overlooked by purely quantitative approaches. The author maintains that incorporating phenomenological perspectives can enhance therapeutic understanding and outcomes in this emerging field.
Aust N Z J Psychiatry May 18, 2026 correction
A corrigendum corrects errors in a previously published article about psilocybin's regulatory, ethical, and operational challenges in Australia's clinical landscape. The original article discussed issues surrounding the real-world use of psilocybin, a psychedelic substance, in therapeutic settings. The corrigendum does not present new findings or arguments but amends specific inaccuracies in the original text.